Skip to content

Study Details

Early Detection of Lung Cancer based on small RNA signatures (Boston II)

(IRB#: IRB_00166058)

This study will see if a new test can diagnose lung cancer. The new test is called the HBDx small RNA diagnostic test for lung cancer. People in this study will participate for 12 months. You will give blood at one clinic visit at the start of the study. This blood will be used to run the new test. We will collect information from your medical record for 12 months after the visit. At the end of 12 months, we will contact you to ask about any imaging, biopsies or surgical procedures you might have had at another healthcare facility.


  • All genders
  • Over 18 years old
  • Volunteers with special conditions
  •   In Person
  • Paid

Who can participate?

 Gender: All genders

  Age: Over 18 years old

  Volunteers: Volunteers with special conditions

   Location: In Person

Inclusion Criteria

  • Adult male and female patients, aged 50 to 80 years
  • Had a LDCT (low dose computed tomography scan) in the past 90 days
  • Have been referred to undergo further diagnostic procedures for the detection of lung cancer

Exclusion Criteria

  • Prior history of diagnosed lung cancer
  • History of gastrointestinal, hematological, breast, thyroid, and genitourinary cancer within the past 10 years
  • Active infectious diseases
  • Taking Immunosuppressive medication

Will I be paid for my time?


For more information contact:

Macy Barrios


IRB#: IRB_00166058

PI: Chakravarthy Reddy

Department: PULMONARY

Approval Date: 2023-07-27 16:36:00

Study Categories: Lung Cancer Studies

Specialties: Pulmonary

Last Updated: 6/8/23